申请人:Daiichi Pharmaceutical Co., Ltd.
公开号:US05599813A1
公开(公告)日:1997-02-04
Thiazolopyrimidine derivatives represented by the formula ##STR1## and salts thereof are provided, which are characterized by a carboxamide residue substituted with R.sup.4 and R.sup.5. The derivatives and salts thereof exhibit antiangiogenic activity and are useful for treatment and cure of diseases, the development of which may be related to angiogenesis, including diabetic retinopathy, various chronic inflammation conditions, growth or metastasis of malignant solid tumors, rheumatism and psoriasis.
提供了由公式##STR1##表示的噻唑吡咯啉衍生物及其盐,其特征在于带有R.sup.4和R.sup.5取代的羧酰胺残基。这些衍生物及其盐表现出抗血管生成活性,并可用于治疗和治愈可能与血管生成有关的疾病,包括糖尿病视网膜病变、各种慢性炎症症状、恶性实体肿瘤的生长或转移、风湿病和牛皮癣。